These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32700645)

  • 21. Lymphocyte Non-Specific Function Detection Facilitating the Stratification of
    Luo Y; Xue Y; Cai Y; Lin Q; Tang G; Song H; Liu W; Mao L; Yuan X; Zhou Y; Liu W; Wu S; Sun Z; Wang F
    Front Immunol; 2021; 12():641378. PubMed ID: 33953714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of
    Gong W; Liang Y; Wang J; Liu Y; Xue Y; Mi J; Li P; Wang X; Wang L; Wu X
    Microbiol Spectr; 2022 Aug; 10(4):e0143822. PubMed ID: 35938824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis.
    Qiu X; Tang Y; Zou R; Zeng Y; Yue Y; Li W; Qu Y; Mu D
    Sci Rep; 2019 Aug; 9(1):11408. PubMed ID: 31388072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
    Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
    Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA.
    Nasiri MJ; Pormohammad A; Goudarzi H; Mardani M; Zamani S; Migliori GB; Sotgiu G
    Infection; 2019 Jun; 47(3):353-361. PubMed ID: 30805899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
    Della Bella C; Spinicci M; Grassi A; Bartalesi F; Benagiano M; Truthmann K; Tapinassi S; Troilo A; D'Elios S; Alnwaisri H; Shuralev E; Singh M; Bartoloni A; D'Elios MM
    PLoS One; 2018; 13(6):e0197825. PubMed ID: 29856871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study.
    Li H; Ren W; Liang Q; Zhang X; Li Q; Shang Y; Ma L; Li S; Pang Y
    QJM; 2023 Dec; 116(12):1002-1009. PubMed ID: 37740371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries.
    Chendi BH; Tveiten H; Snyders CI; Tonby K; Jenum S; Nielsen SD; Hove-Skovsgaard M; Walzl G; Chegou NN; Dyrhol-Riise AM
    J Infect; 2021 Oct; 83(4):433-443. PubMed ID: 34333033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Systematic Review on Novel
    Meier NR; Jacobsen M; Ottenhoff THM; Ritz N
    Front Immunol; 2018; 9():2476. PubMed ID: 30473692
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
    Suzukawa M; Akashi S; Nagai H; Nagase H; Nakamura H; Matsui H; Hebisawa A; Ohta K
    PLoS One; 2016; 11(4):e0152483. PubMed ID: 27035669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.
    He J; Fan Y; Shen D; Yu M; Shi L; Ding S; Li L
    Cytokine; 2020 Nov; 135():155218. PubMed ID: 32771857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family.
    Pourakbari B; Mamishi S; Marjani M; Rasulinejad M; Mariotti S; Mahmoudi S
    Mol Diagn Ther; 2015 Oct; 19(5):309-16. PubMed ID: 26245995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
    Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Gene Expression of ASUN, NEMF, PTPRC and DHX29: Candidate Biomarkers for the Diagnosis of Active and Latent Tuberculosis.
    Mamishi S; Pourakbari B; Sadeghi RH; Marjani M; Mahmoudi S
    Infect Disord Drug Targets; 2021; 21(2):268-273. PubMed ID: 32167431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.
    Delemarre EM; van Hoorn L; Bossink AWJ; Drylewicz J; Joosten SA; Ottenhoff THM; Akkerman OW; Goletti D; Petruccioli E; Navarra A; van den Broek BTA; Paardekooper SPA; van Haeften I; Koenderman L; Lammers JJ; Thijsen SFT; Hofland RW; Nierkens S
    Front Immunol; 2021; 12():725447. PubMed ID: 34691031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy.
    Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY
    Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.